Renae Adams
About Renae Adams
Renae Adams is the Associate Director of Tumor Treating Fields Specialists at Novocure, with a background in nursing and extensive experience in oncology education and medical science liaison roles.
Current Role at Novocure
Renae Adams currently serves as the Associate Director for Tumor Treating Fields Specialists at Novocure. In this role, she focuses on physician development, speaker training, and managing adverse events. Her responsibilities also include analyzing territory usage data to plan customer visits and grow business. Additionally, she collaborates with sales leadership and marketing teams to identify and support Optune champions in her territory.
Previous Experience at Novocure
Before her current role, Renae Adams worked as a Thought Leader Liaison at Novocure from 2017 to 2021. During her tenure, she played a crucial role in educating healthcare professionals on the mechanisms of action, treatment profiles, and clinical trial data for Optune and Optune Lua. Her work was instrumental in supporting thought leaders in the field of oncology and enhancing the overall understanding of Novocure’s offerings.
Career in Oncology at Various Companies
Renae Adams has a diverse background in oncology, having held roles at multiple organizations. From 2015 to 2017, she worked as an Oncology Partner at Merrimack, and prior to that, she served as a Clinical Nurse Educator at Onyx Pharmaceuticals, Inc., an Amgen subsidiary, from 2014 to 2015 in Aurora, Colorado. She also spent a year at Quintiles in a similar role from 2013 to 2014, also based in Aurora, Colorado.
Educational Background
Renae Adams has a solid educational foundation in nursing. She earned her Bachelor’s degree in Registered Nursing from Kaplan University in 2012. Furthering her education, she completed her Master of Science in Nursing (MSN) at Walden University with a focus on Family Practice Nurse/Nursing, completing the program in 2019.
Expertise in Medical Science Liaison Roles
Renae Adams brings extensive expertise in Medical Science Liaison (MSL) roles to her current position. Her experience includes Investigator-Sponsored Trials (IST) development, pipeline discussions, and drug launches. She has played a key role in ensuring appropriate reimbursement for both inpatient and outpatient infusion settings. This includes delivering presentations for large payer groups and providing guidance to clinics requiring drug replacement or patient assistance.